New Survey From National Comprehensive Cancer Network Finds Cancer Drug Shortage Management Remains a Moving Target, Impacting Clinical Trials
June 27, 2024
June 27, 2024
PLYMOUTH MEETING, Pennsylvania, June 27 (TNSres) -- The National Comprehensive Cancer Network issued the following news release:
* * *
Specific carboplatin and cisplatin shortages fell to 11% and 7% respectively, but 89% of centers surveyed continue to report shortages for at least one type of systemic therapy; 75% are experiencing two or more drug shortages.
* * *
The National Comprehensive Cancer Network(R) (NCCN(R))--a nonprofit alliance of . . .
* * *
Specific carboplatin and cisplatin shortages fell to 11% and 7% respectively, but 89% of centers surveyed continue to report shortages for at least one type of systemic therapy; 75% are experiencing two or more drug shortages.
* * *
The National Comprehensive Cancer Network(R) (NCCN(R))--a nonprofit alliance of . . .